Literature DB >> 30339507

Evaluating Virulence-Associated Genes and Antimicrobial Resistance of Avian Pathogenic Escherichia coli Isolates from Broiler and Broiler Breeder Chickens in Ontario, Canada.

Csaba Varga1,2, Marina L Brash3, Durda Slavic3, Patrick Boerlin2, Rachel Ouckama4, Alexandru Weis5, Mike Petrik6, Cynthia Philippe7, Melanie Barham3, Michele T Guerin8.   

Abstract

Avian pathogenic Escherichia coli (APEC) is the causative agent of colibacillosis in poultry, an economically important disease worldwide. In Ontario, Canada, early and late systemic bacterial infections due to APEC were the most commonly reported diseases in broiler chickens. In 2016, Ontario poultry veterinarians submitted samples from 331 cases of broiler and broiler breeder chickens with a high suspicion of colibacillosis to the Animal Health Laboratory (Guelph, Ontario, Canada) for bacterial culture. Escherichia coli isolates from those samples were tested with multiplex PCR to detect the presence of 13 virulence-associated genes. The most common genes identified were sitA (detected in 93% of isolates), iss (88%), iroN (85%), iutA (79%), ompT (77%), and etsB (67%). In 94% of isolates, at least three virulence-associated genes were detected. Antimicrobial susceptibility testing of isolates by using the disk diffusion method revealed high frequencies of resistance to tetracycline (57% of isolates), gentamicin (50%), spectinomycin (46%), and ampicillin (44%). Relatively fewer isolates were resistant to trimethoprim-sulfamethoxazole (18%), ceftiofur (15%), kanamycin (11%), and apramycin (3%). A high proportion (46%) of the isolates were multidrug resistant (≥3 antimicrobial classes). On the basis of multivariable, mixed effects logistic regression models, statistically significant associations ( P ≤ 0.05) were identified between the following: ampicillin resistance and the presence of kpsII (odds ratio [OR] = 1.88), tsh (OR = 0.46), and ireA (OR = 0.32); ceftiofur resistance and etsB (OR = 2.98) and kpsII (OR = 2.61); gentamicin resistance and ompT (OR = 3.89) and sitA (OR = 3.54); kanamycin resistance and papC (OR = 50.10); spectinomycin resistance and ireA (OR = 2.50) and iutA (OR = 3.15); trimethoprim-sulfamethoxazole resistance and ompT (OR = 0.14) and tsh (OR = 0.31); and tetracycline resistance and cvaC (OR = 2.12), eitA (OR = 2.15), and papC (OR = 8.27). On the basis of a multivariable, mixed effects Poisson regression model, the number of antimicrobials to which an isolate was resistant increased with the presence of eitA (risk ratio [RR] = 1.37), iroN (RR = 1.24), papC (RR = 1.34), and sitA (RR = 1.77) and decreased with the presence of tsh (RR = 0.79). On the basis of bivariable logistic regression models, age group and time of sample collection were not significantly associated with resistance to individual antimicrobials, the presence of multidrug resistance, or the presence of virulence-associated genes. Our results provide information on antimicrobial resistance and virulence gene patterns currently present on Ontario broiler chicken and broiler breeder farms that can be used as a benchmark from which to measure changes.

Entities:  

Keywords:  Canada; Ontario; antimicrobial resistance; avian pathogenic Escherichia coli; broilers; multidrug resistance; virulence genes

Mesh:

Substances:

Year:  2018        PMID: 30339507     DOI: 10.1637/11834-032818-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  8 in total

1.  A retrospective analysis of antimicrobial resistance in pathogenic Escherichia coli and Salmonella spp. isolates from poultry in Uganda.

Authors:  Steven Kakooza; Adrian Muwonge; Esther Nabatta; Wilfred Eneku; Dickson Ndoboli; Eddie Wampande; Damian Munyiirwa; Edrine Kayaga; Maria Agnes Tumwebaze; Mathias Afayoa; Paul Ssajjakambwe; Dickson Stuart Tayebwa; Sayaka Tsuchida; Torahiko Okubo; Kazunari Ushida; Ken'ichi Sakurai; Francis Mutebi
Journal:  Int J Vet Sci Med       Date:  2021-05-19

2.  Molecular characteristics of fluoroquinolone-resistant avian pathogenic Escherichia coli isolated from broiler chickens.

Authors:  Mi Young Yoon; Yeong Bin Kim; Jong Su Ha; Kwang Won Seo; Eun Bi Noh; Se Hyun Son; Young Ju Lee
Journal:  Poult Sci       Date:  2020-04-15       Impact factor: 3.352

3.  Molecular identification, genotyping of virulence-associated genes, and pathogenicity of cellulitis-derived Escherichia coli.

Authors:  Mohamed M Amer; Hoda M Mekky; Hanaa S Fedawy; A El-Shemy; M A Bosila; Kh M Elbayoumi
Journal:  Vet World       Date:  2020-12-19

4.  Characterizing avian pathogenic Escherichia coli (APEC) from colibacillosis cases, 2018.

Authors:  Darby M Newman; Nicolle L Barbieri; Aline L de Oliveira; Dajour Willis; Lisa K Nolan; Catherine M Logue
Journal:  PeerJ       Date:  2021-03-04       Impact factor: 2.984

Review 5.  Avian Pathogenic Escherichia coli (APEC): An Overview of Virulence and Pathogenesis Factors, Zoonotic Potential, and Control Strategies.

Authors:  Dipak Kathayat; Dhanashree Lokesh; Sochina Ranjit; Gireesh Rajashekara
Journal:  Pathogens       Date:  2021-04-12

6.  Prevalence and Molecular Characteristics of Avian Pathogenic Escherichia coli in "No Antibiotics Ever" Broiler Farms.

Authors:  Courtney A Fancher; Hudson T Thames; Mary Gates Colvin; Mercedes Smith; Alyssa Easterling; Nikhil Nuthalapati; Li Zhang; Aaron Kiess; Thu T N Dinh; Anuraj Theradiyil Sukumaran
Journal:  Microbiol Spectr       Date:  2021-12-08

7.  Associations between antimicrobial resistance in fecal Escherichia coli isolates and antimicrobial use in Canadian turkey flocks.

Authors:  Rima D Shrestha; Agnes Agunos; Sheryl P Gow; Anne E Deckert; Csaba Varga
Journal:  Front Microbiol       Date:  2022-07-29       Impact factor: 6.064

8.  Antimicrobial resistance in fecal Escherichia coli and Salmonella enterica isolates: a two-year prospective study of small poultry flocks in Ontario, Canada.

Authors:  Csaba Varga; Michele T Guerin; Marina L Brash; Durda Slavic; Patrick Boerlin; Leonardo Susta
Journal:  BMC Vet Res       Date:  2019-12-21       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.